RoccoMichaelFerrandinoIIMDMSCR

Otolaryngology (ENT) • Seattle, WA

Head & Neck Microvascular Surgery, Head & Neck Oncologic Surgery

Physician

Join to view full profile

Dr. Ferrandino is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ferrandino's full profile

Already have an account?

Office
University of Washington Medical Center
1959 NE Pacific St
Seattle, WA 98195

Education & Training

University of WashingtonFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2023 - 2024
Icahn School of Medicine at Mount Sinai/New York Eye and Ear Infirmary at Mount SinaiResidency, Otolaryngology - Head and Neck Surgery, 2018 - 2023
Icahn School of Medicine at Mount SinaiClass of 2017

Certifications & Licensure

WA State Medical License 2023 - 2026

Publications & Presentations

PubMed

68 citations
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
Joshua Bauml, Ravi Vinnakota, Yeun-Hee Anna Park, Susan E. Bates, Tito Fojo
Journal of the National Cancer Institute. 2019-05-01
7 citations
Lymph Node Ratio in HPV-Associated Oropharyngeal Cancer: Identification of a Prognostic Threshold.
Daniel D. Bu, Rocco Ferrandino, Eric M. Robinson, Shelley H. Liu, Brett A. Miles
The Laryngoscope. 2021-01-01
6 citations
The Sinai Robotic Surgery Trial in HPV-related oropharyngeal squamous cell carcinoma (SIRS 2.0 trial) - study protocol for a phase II non-randomized non-inferiority tr...
Raymond L Chai, Rocco M Ferrandino, Christine Barron, Kianoush Donboli, Scott A Roof
Frontiers in Oncology. 2022-01-01

Press Mentions

Liquid Biopsy May Help May Identify HPV-Associated Oropharyngeal CancerJuly 16th, 2023